Product Description
Introduction
The prevalence of hip fractures, a condition related to osteopenia and osteoporosis, increased during the latter half of the 20th century but has since leveled off or decreased in most markets. The current combined prevalence of osteopenia and osteoporosis is estimated at approximately 55% among people aged 50 and older and the total number of cases is expected to grow over the next decade.
Features And Benefits
• Gain insight to market potential, including a robust 10-year epidemiology forecast of osteopenia and osteoporosis total prevalent cases.
• Understand the key epidemiologic risk factors associated with osteopenia, osteoporosis, and severe osteoporosis.
Highlights
During 2010, Datamonitor estimates that 117.9, 15.0, and 4.3 million total prevalent cases of osteopenia, osteoporosis, and severe osteoporosis, respectively, existed in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK).
Between 2010 and 2020, Datamonitor forecasts osteopenia, osteoporosis, and severe osteoporosis total prevalent cases in the seven major markets to increase by 14%, 17%, and 24%, resulting in 134.8 million, 17.5 million, and 5.3 million total prevalent cases in 2020, respectively.
Datamonitor estimates that in 2010, most total prevalent osteopenia, osteoporosis, and severe osteoporosis cases were in women (71.8 million or 61% of all cases; 12.4 million or 82% of all cases, and 3.75 million or 88% of all cases, respectively).
Your Key Questions Answered
• What are the most robust sources for osteopenia and osteoporosis prevalence data?
• How will the patient population change over the next decade in the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK)?
• How do changes in population structure and risk factors affect the trend in prevalent osteopenia and osteoporosis cases?
Table of Contents
Executive Summary
Disease burden overview
Forecast results (2010-20)
Osteopenia
Osteoporosis
Related reports
OVERVIEW
Catalyst
Summary
DISEASE DEFINITION AND DIAGNOSIS CRITERIA
Diagnosis and testing for osteopenia and osteoporosis
Classification of osteopenia and osteoporosis
GLOBAL VARIATION AND HISTORICAL TRENDS
Disease burden overview
Global variation
Historical trends
DRIVERS OF OSTEOPOROSIS/OSTEOPENIA EPIDEMIOLOGY
Potential drivers
Age
Exercise and activity
Weight
Medication
Smoking, alcohol, and caffeine
Other risk factors
Age at menopause
Calcium and vitamin D
Genetics
History of fracture
Race and ethnicity
Co-morbid conditions that alter epidemiology
EPIDEMIOLOGIC FORECASTING OF OSTEOPENIA AND OSTEOPOROSIS
Overview
Population denominators
Subpopulations
Age
Sex
Age-standardized prevalence
US
Sources used
Methods
Sources not used
Japan
Sources used
Methods
Sources not used
France
Sources used
Methods
Sources not used
Germany
Sources used
Methods
Sources not used
Italy
Sources used
Methods
Sources not used
Spain
Sources used
Methods
Sources not used
UK
Sources used
Methods
Sources not used
EPIDEMIOLOGIC RESULTS
Estimated total prevalent cases of osteopenia and future trends
Estimated total prevalent cases of osteoporosis and severe osteoporosis and future trends
Segmentation by age group
Osteopenia
Osteoporosis and severe osteoporosis
Segmentation by sex
Osteopenia
Osteoporosis and severe osteoporosis
DISCUSSION
Strengths and limits of Datamonitor’s epidemiologic projections
BIBLIOGRAPHY
Journal papers
Websites
Datamonitor reports
Appendix
Module methodology
